X-rays actuate anticancer drugs: Opening new vistas in prodrug therapy

Chembiochem. 2021 Aug 18. doi: 10.1002/cbic.202100373. Online ahead of print.ABSTRACTChemotherapy is the primary treatment modality employed in the clinic for the treatment of cancer. Despite proven clinical success, adverse side effects are one of the drawbacks of this approach. The prodrug strategy has emerged as an alternative approach with the aim of alleviating these drawbacks. Prodrug activation is typically achieved by either endogenous or exogenous triggers. Exogenous triggers like light are appealing as they are independent of inherent patient and/or cancer type variations. However, tissue penetration depth remains the Achilles'heel of this approach. In this context, usage of X-rays as the external trigger with infinite tissue penetration depth opens up exciting prospects in prodrug activation strategies.PMID:34406685 | DOI:10.1002/cbic.202100373
Source: Chembiochem - Category: Biochemistry Authors: Source Type: research